Aerotel Medical System Form an Alliance with Italian Leading Telemedicine Services Provider Telbios

TelbiosTelbios, the leading telemedicine services provider in Italy, has signed an exclusivity agreement with Aerotel Medical System, world leader in manufacturing of medical devices and software platforms for telemedicine and Home Care services, for exclusive marketing and distribution of Aerotel innovative products in the Italian market.

AerotelThe agreement with Aerotel expands the range of telemedicine and home care services offered by Telbios, which includes Tele-assistance, Tele-cardiology, and Tele-radiology services. Health organizations such as hospitals, private and public healthcare institutions can now offer their patients a simple and efficient means to monitor the state of their health.

"The agreement with Aerotel is important since it gives us access to devices and technologies that are state of the art and that complete Telbios’s range of services offered," says Leopold Genovesi, CEO of Telbios.

Aerotel's devices such as EKG machines allow the patients to self measure the cardiologic parameters and send them, in short time, via telephone or GSM mobile phone handset, from any location to the call center. The transmitted information can be instantly interpreted by the team of cardiologists of San Raffaele Scientific Institute in Milan working within Telbios Telemedicine Service Center on a 24 hours call basis and immediately sent to the attending GP of the patient.

"Thanks to this technology the chronically ill patients can now avail of those technologies and are offered the possibility to be monitored without leaving the comfort of their home or while travelling and still follow a tight treatment protocol that results in the benefit of their quality of life," conclude Genovesi.

"Telemedicine is a growing market all over the globe and in Italy we can also see a very positive growth," says David Rubin, President & CEO of Aerotel Medical Systems."Having Telbios as a business partner will allow us both to develop dedicated solutions to the growing Italian market."

Monitoring the chronically ill patients can be considered as an emergency on a national level: in Italy there are over 2.5 million diabetic patients, over 4 million patients suffering for respiratory dysfunction, one million of patients suffering form chronic heart failure and the number of patients under anticoagulation treatment exceeds one million. Patients with two or more chronic diseases are the 19.4% of the population.

Telemedicine is the most suitable remote follow up method for the cited pathologies. Telemedicine reduces the unnecessary hospitalizations and reduces waiting lists for medical treatment with a significant saving factor on economical resources.

TELBIOS S.p.A.
Ufficio Stampa
Danilo Magliano
Tel .: +39 02 26433759
Mobile: +39 3357 563583
Web: www.telbios.it
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Aerotel
Hazoref st. 5, Holon 58856, Israel
Tel.: +972 3 559 3222
Fax: +972 3 559 6111
Web: www.aerotel.com
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

About Telbios
Telbios is the Italian company leader for Telemedicine services and networks in civil and military health care structures, and for Home Care assistance, proposing services and customer oriented solutions.

Telbios features his services thanks to the assistance supplied by Telemedicine Service Center (TSC) where 24 h a day technic specialist operators and specialist phisicians are on hand for customer clinic data and diagnostic images recipt, management, archiving, monitoring and reporting. CST ensures a protect data access to information about single patient and enables the web clinic data sharing, with emergency intervention activity at every time.
For more information about Telbios, please visit Telbios website at www.telbios.com

About Aerotel Medical Systems
Aerotel Medical Systems is a world leader in cost-effective, high quality, user-friendly, medical diagnostic systems and devices for the home care, eHealth and Telemedicine markets. The company provides a complete disease management package, including transtelephonic Portable devices designed for a variety of remote diagnostic, and monitoring applications; a hardware and software platform; plus phone and web-based software.

Established in 1985, Aerotel has implemented its solutions in the USA, Europe, India, China, Australia, South America and many other countries worldwide.Frost & Sullivan has recently named Aerotel as "Company of the year" for the European telemedicine market. Aerotel products are CE marked and FDA cleared for marketing in the US with the intention to be used by patients themselves. They are designed for simple use and are famous for their quality and reliability.
For more information about Aerotel, please visit Aerotel website at www.aerotel.com

Most Popular Now

AI in Personalized Cancer Medicine: New …

The application of AI in precision oncology has so far been largely confined to the development of new drugs and had only limited impact on the personalisation of therapies. New...

AI can Predict Brain Cancer Patients…

Artificial Intelligence (AI) can predict whether adult patients with brain cancer will survive more than eight months after receiving radiotherapy treatment. The use of the AI to successfully predict patient outcomes...

Max Planck Institute for Informatics and…

The Max Planck Institute for Informatics and Google deepen their strategic research partnership. With additional financial support from the U.S. IT company, the "Saarbrücken Research Center for Visual Computing, Interaction...

JMIR Medical Informatics Invites Submiss…

JMIR Publications has announced a new section titled, "AI Language Models in Health Care" in JMIR Medical Informatics. This leading peer-reviewed journal is indexed in PubMed and has a unique...

Paper Calls for Patient-First Regulation…

Ever wonder if the latest and greatest artificial intelligence (AI) tool you read about in the morning paper is going to save your life? A new study published in JAMA...

Could ChatGPT Help or Hurt Scientific Re…

Since its introduction to the public in November 2022, ChatGPT, an artificial intelligence system, has substantially grown in use, creating written stories, graphics, art and more with just a short...

Evaluating the Performance of AI-Based L…

A new study evaluates an artificial intelligence (AI)-based algorithm for autocontouring prior to radiotherapy in head and neck cancer. Manual contouring to pinpoint the area of treatment requires significant time...

Making AI a Partner in Neuroscientific D…

The past year has seen major advances in Large Language Models (LLMs) such as ChatGPT. The ability of these models to interpret and produce human text sources (and other sequence...

Chapman Scientists Code ChatGPT to Desig…

Generative artificial intelligence platforms, from ChatGPT to Midjourney, grabbed headlines in 2023. But GenAI can do more than create collaged images and help write emails - it can also design...

DMEA nova Award: Wanted - Visionary Solu…

9 - 11 April 2024, Berlin, Germany. The DMEA nova Award is being presented at DMEA 2024 for the first time. The award honours a digital health startup for an outstanding...

New Digital Therapy Reduces Anxiety and …

A therapist-guided digital cognitive behavioural therapy reduced distress in 89 per cent of participants living with long-term physical health conditions, a new King's College London study finds. Researchers at the Institute...

Europe's Digital Health Industry Me…

9 - 11 April 2024, Berlin, Germany. In just over two months, from 9 to 11 April 2024, DMEA, Europe's leading event for digitalisation of healthcare, will gather digital health experts...